News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|March 31, 2023

Honoring Endometriosis Awareness Month

Author(s)Morgan Ebert

To close out Endometriosis Awareness Month in March, Rachel Cullifer, MD, discusses clinical pearls for diagnosis and treatment, as well as some common misconceptions about endometriosis.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections | Image credit: Contemporary OB/GYN

FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections

ByJoshua Fitch, Senior Editor ,Benjamin P. Saylor

June 17th 2026

Mark Simon, MD, MMM, on the hospitalist care model

Mark Simon, MD, MMM, on the OB hospitalist care model

ByMark Simon, MD, MMM

June 10th 2026

Clinical pearls into new postmenopausal guidelines from ACOG, with Susan Loeb-Zeitlin, MD, FACOG

Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG

BySusan E. Loeb-Zeitlin, MD, FACOG

June 4th 2026

Individualized TRT demonstrates broad symptom improvements beyond sexual function

Individualized TRT demonstrates broad symptom improvements beyond sexual function

ByMelissa Loseke, DO

June 2nd 2026

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

ByJoshua Fitch, Senior Editor

June 1st 2026

Latest CME

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections

Over half of elinzanetant's sleep benefit is VMS-independent

Fiona Baker, PhD, details elinzanetant's effectiveness on wakefulness after sleep onset in postmenopausal women

Stephanie Faubion, MD, MBA, on untangling sleep disorders from VMS in menopausal women

NIRVANA: Elinzanetant cuts objective wakefulness in menopausal women